After saying the CLBP work is underway in Jan, they got told about the potential AA pathway for heart. That would be a good reason for a go-slow for CLBP or rethinking the priorities, would it not, for how to spend limited cash? There is more than meets the eye. I would reserve my judgment on this.
Also, there’s a 3rd financing option by way of royalty monetisation but that only makes sense if they get approval for Ryoncil, then they can capitalise the Japanese income stream or fo something along those lines.
Ann: Annual Financial Results Presentation, page-94
-
- There are more pages in this discussion • 117 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.49 |
Change
0.140(10.4%) |
Mkt cap ! $1.701B | |||
| Open | High | Low | Value | Volume |
| $1.37 | $1.54 | $1.37 | $23.10M | 15.82M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 24758 | $1.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.49 | 73626 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |